PT  - JOURNAL ARTICLE
AU  - McPherson, Susan
AU  - Freedman, David E.P.
TI  - Psychological outcomes of 12-15-year-olds with gender dysphoria receiving pubertal suppression: assessing reliable and clinically significant change
AID  - 10.1101/2023.05.30.23290763
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.05.30.23290763
4099  - http://medrxiv.org/content/early/2023/08/08/2023.05.30.23290763.short
4100  - http://medrxiv.org/content/early/2023/08/08/2023.05.30.23290763.full
AB  - The evidence base for psychological benefits of GnRHA treatment for adolescents with gender dysphoria (GD) has been deemed “low quality” by the UK National Institute of Health and Care Excellence, limitations including inattention to clinical importance of findings. This secondary analysis of UK clinical study data uses Reliable and Clinically Significant Change approaches to fill this gap in the evidence. The original uncontrolled study collected data within a specialist GD service. Participants were 44 12-15-year-olds diagnosed with GD. Puberty was suppressed using “triptorelin”; participants were followed-up for 36 months. Secondary analysis used data from the parent-report Child Behaviour Checklist and the Youth Self-Report forms. Reliable change results: 15-34 percent of participants reliably deteriorated depending on the subscale and time point. Clinically significant change results: 37-58 percent were in the borderline or clinical range at baseline (depending on scale). Of these, rates of clinically significant change were low and fell to zero at endpoints on both self-report and parent-report. The approach offers an established complementary method to analyse individual level change and to examine who might benefit or otherwise from treatment in a field where research designs have been challenged by lack of control groups and low sample sizes.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNA (secondary analysis)Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used ONLY openly available human data that were originally located at https://doi.org/10.5255/UKDA-SN-854413I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data underlying the results presented in this study are available from the UK Data Service (DOI: 10.5255/UKDA-SN-854413). https://doi.org/10.5255/UKDA-SN-854413